| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 12/14/2005 | CN1231599C Gene synapsin II associated with schizophrenia and polymorphism site and use thereof |
| 12/14/2005 | CN1231598C Process for recombining aviadenovirus |
| 12/14/2005 | CN1231597C Septicaemia detection chip, its preparation process and application method |
| 12/14/2005 | CN1231596C Method for making animal genetic information identification by utilizing mtDNA fingerprint |
| 12/14/2005 | CN1231589C Eukaryotic gene expression cassette and uses thereof |
| 12/14/2005 | CN1231573C Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents |
| 12/14/2005 | CN1231492C Solution phase synthesis of oligonucleotides |
| 12/14/2005 | CN1231491C Mammal telomerase |
| 12/13/2005 | US6975943 Clone-array pooled shotgun strategy for nucleic acid sequencing |
| 12/13/2005 | US6975893 Mass transport limited in vivo analyte sensor |
| 12/13/2005 | US6975403 On-line method and equipment for detecting, determining the evolution and quantifying a microbial biomass and other substances that absorb light along the spectrum during the development of biotechnological processes |
| 12/13/2005 | US6975400 Imaging and analyzing parameters of small moving objects such as cells |
| 12/13/2005 | US6974864 Viral mucleotide sequences for use in the diagnosis and treatment of viral diseases |
| 12/13/2005 | US6974707 co-immobilization with photolinker; dextran is attached to carrier through component resulting from irradiation of 3-trifluoromethyl-3-(m-isothiocyanophenyl)-diazirine-modified aminodextran; polyimide/polyxylylene protective films; transducers |
| 12/13/2005 | US6974704 Mass spectrometric immunoassay |
| 12/13/2005 | US6974703 Electro-optical devices and methods for hybridization and detection |
| 12/13/2005 | US6974702 Fourier transform mass spectrometry of complex biological samples |
| 12/13/2005 | US6974700 Apparatus for detecting bacterial infections of mouth and diagnosing gum diseases; dentistry |
| 12/13/2005 | US6974699 Pharmaceuticals and assays using enzyme subunits |
| 12/13/2005 | US6974688 Nucleotide sequences coding preferential plypeptide for use in the diagnosis and treatment of hypertension, hypotension, heart disease, asthma, and the like. |
| 12/13/2005 | US6974686 Recombinant tryptophan mutants of influenza |
| 12/13/2005 | US6974679 Support with collagen base for tissue engineering and manufacture of biomaterials |
| 12/13/2005 | US6974676 spectrophotometric bioassay for protein lipid transferase and cholesteryl ester transfer protein activity; fluorophore label |
| 12/13/2005 | US6974675 Based on immune cells expressing specific proteins which bind to endothelioid cells of blood vessels in brain and muscle tissue in a specific protein combintion pattern; depositing a cell mixture on target cell surfaces |
| 12/13/2005 | US6974672 Diagnosing ovavrian and colon tumors via over expression of cathepsin Z (CTSZ) and CD24 gene products; gene therapy; drug screening; antitumor agents; gene expression inhibition |
| 12/13/2005 | US6974671 Determine expression level of Potentiated GlucoCorticoid induction protein, PGC-1, or mRNA; diagnose predisposition to diabetes mellitus; drug screening |
| 12/13/2005 | US6974670 Method of synthesizing nucleic acid |
| 12/13/2005 | US6974669 Bio-barcodes based on oligonucleotide-modified nanoparticles |
| 12/13/2005 | US6974668 antitumor agent binds to base DNA or RNA sequence; measure cytolysis of tumor cells; drug screening |
| 12/13/2005 | US6974667 Detecting the level of expression in a tissue sample of two or more genes; wherein differential expression of the genes is indicative of liver cancer |
| 12/13/2005 | US6974666 bioassay preparing libraries of diverse DNA sequences and probes for use in screening studies; molecular hybridization, splicing with nucleases and removing non-complementary sections; quantitative fluorescence analysis |
| 12/13/2005 | US6974665 In situ screening to optimize variables in organic reactions |
| 12/13/2005 | US6974294 Article handling system and method |
| 12/13/2005 | US6973706 Comprises forming channels in surfaces of the substrate, and disposing conductive material by non-impact printing to form electrode/sensor; biocompatability |
| 12/13/2005 | CA2001328C Borrelia antigen |
| 12/09/2005 | CA2489935A1 Method for measuring polyamines in erythrocytes, diagnostic method and kit for measuring polyamines in erythrocytes |
| 12/08/2005 | WO2005116901A2 Method of diagnosing the presence and/or severity of a hepatic pathology in an individual and/or of monitoring the effectiveness of a treatment for one such pathology |
| 12/08/2005 | WO2005116850A2 Polynucleotides and polypeptides of ovarian cancer |
| 12/08/2005 | WO2005116657A2 Identification of ergothioneine transporter and therapeutic uses thereof |
| 12/08/2005 | WO2005116645A2 Isolation of allergen-specific immunoglobulin genes from human b-cells from atopy sufferers |
| 12/08/2005 | WO2005116639A1 Method, specific primers and kit for the detection of neisseria meningitidis |
| 12/08/2005 | WO2005116624A1 Highly sensitive method of detecting single nucleotide polymorphism with the use of photocurrent |
| 12/08/2005 | WO2005116622A1 Connector configuration for electrochemical cells and meters for use in combination therewith |
| 12/08/2005 | WO2005116270A2 Influenza virus vaccine composition and method of use |
| 12/08/2005 | WO2005116269A1 Method of screening sample having antiviral activity against virus with ability to infect organism exhibiting acquired immune mechanism by use of individual organism, or its cultured cell, exhibiting natural immune mechanism only, and method of estimating the antiviral activity by use of individual organism, or its cultured |
| 12/08/2005 | WO2005116268A2 Differential expression of molecules associated with acute stroke |
| 12/08/2005 | WO2005116267A2 Emission ratiometric indicators of phosphorylation by c-kinase |
| 12/08/2005 | WO2005116266A2 Methods of amplifying infectious proteins |
| 12/08/2005 | WO2005116265A2 Probe arrays for expression profiling of rat genes |
| 12/08/2005 | WO2005116264A2 A blood test to monitor the genetic changes of progressive cancer using immunomagnetic enrichment and fluorescence in situ hybridization (fish) |
| 12/08/2005 | WO2005116263A2 Methods for rapid forensic analysis of mitochondrial dna |
| 12/08/2005 | WO2005116262A1 Methods and devices for sequencing nucleic acids |
| 12/08/2005 | WO2005116261A2 Rna expression microarrays |
| 12/08/2005 | WO2005116260A2 Influenza hemagglutinin and neuraminidase variants |
| 12/08/2005 | WO2005116259A2 Use of gene expression profiling to predict survival in cancer patient |
| 12/08/2005 | WO2005116258A2 Influenza hemagglutinin and neuraminidase varians |
| 12/08/2005 | WO2005116257A2 Unique short tandem repeats and methods of their use |
| 12/08/2005 | WO2005116256A2 Device for extracting biological molecules from tissue specimens |
| 12/08/2005 | WO2005116255A2 Aptamer-toxin molecules and method for using same |
| 12/08/2005 | WO2005116254A1 Method of quantitatively evaluating dna methylation |
| 12/08/2005 | WO2005116253A1 Probe for diagnosis of marfan’s syndrome and method of screening with the probe |
| 12/08/2005 | WO2005116252A2 Methods for evaluating ribonucleotide sequences |
| 12/08/2005 | WO2005116251A1 Methods, kits and pharmaceutical compositions for diagnosing, delaying onset of, preventing and/or treating osteoporosis |
| 12/08/2005 | WO2005116250A2 Viral and viral associated mirnas and uses thereof |
| 12/08/2005 | WO2005116249A1 Predictive marker for the evolution of melanomas and applications thereof |
| 12/08/2005 | WO2005116248A1 Method for quantitative and/or comparative measurement of mrna expression levels in small biological samples |
| 12/08/2005 | WO2005116247A1 Method and device for the in vitro detection of polycystic ovarian syndrome (pcos) and pathologies involving cardiovascular risk |
| 12/08/2005 | WO2005116246A2 Method and device for detection of splice form and alternative splice forms in dna or rna sequences |
| 12/08/2005 | WO2005116245A2 Cdna production from cells after laser microdissection |
| 12/08/2005 | WO2005116244A1 Sensor arrangement comprising an electrode for detecting diffused loaded particles |
| 12/08/2005 | WO2005116243A2 Improvements to diagnostic assays that use mycobacteriophages |
| 12/08/2005 | WO2005116242A1 Medicine safety testing method and medicine safety testing system |
| 12/08/2005 | WO2005116241A1 Method of judging properties of mammalian cell and method of diagnosing cancer |
| 12/08/2005 | WO2005116240A2 System for amplyfing optical detection cantilever deflection |
| 12/08/2005 | WO2005116239A2 Diagnostic assays for neurodegenerative diseases |
| 12/08/2005 | WO2005116208A1 Dna amplification method |
| 12/08/2005 | WO2005116205A1 Marker genes for judging paclitaxel-sensitivity and judgment method |
| 12/08/2005 | WO2005116197A2 Adamts-8 proteins and uses thereof |
| 12/08/2005 | WO2005116195A2 Method for identifying pde5-modulators |
| 12/08/2005 | WO2005116191A1 Method of culturing embryonic stem cells with the use of amniotic membrane-origin factor |
| 12/08/2005 | WO2005115737A2 System and method for detecting and identifying an analyte |
| 12/08/2005 | WO2005115622A1 Porous substrate plates and the use thereof |
| 12/08/2005 | WO2005115483A1 Assay for transmissible spongiform encephalopathies |
| 12/08/2005 | WO2005115482A2 Methods for identifying chemical modulators of ras superfamily gtpase activity |
| 12/08/2005 | WO2005115461A2 Pharmaceutical composition for modulating the activity of triglyceride hydrolase |
| 12/08/2005 | WO2005115136A2 Transgenic models of alzheimer’s disease and uses thereof in the treatment of a variety of neurodegenerative diseases |
| 12/08/2005 | WO2005115115A2 Method of measuring cancer susceptibility |
| 12/08/2005 | WO2005098422A3 Detecting recessive diseases in inbred populations |
| 12/08/2005 | WO2005091956A3 In vitro test system for predicting patient tolerability of therapeutic agents |
| 12/08/2005 | WO2005089442A3 Inhibitors of gob-4 protein as asthma therapeutics |
| 12/08/2005 | WO2005086061A3 Estimation of clinical cut-offs |
| 12/08/2005 | WO2005083125A3 Surrogate markers of neuropathic pain |
| 12/08/2005 | WO2005082098A3 Polony fluorescent in situ sequencing beads |
| 12/08/2005 | WO2005082080A3 Method to modulate the immune system with a novel guanine nucleotide exchange factor |
| 12/08/2005 | WO2005078126A3 Means for detecting and treating cancer cells resistant to therapeutic agents |
| 12/08/2005 | WO2005075679A3 Antigenic hiv-1 peptides |
| 12/08/2005 | WO2005073338A3 Fluorescent, semi-conductive polymers, and devices comprising them |
| 12/08/2005 | WO2005071112A3 Molecular analysis |
| 12/08/2005 | WO2005060721A3 Manipulation of rna interference through modulation of armitage activity |
| 12/08/2005 | WO2005059172A3 Method and nucleic acids for the improved treatment of breast cell proliferative disorders |